2Rouieau JC.Treatment of scvere drug eruptions[Z].J Dermatol 19992,26(11):718-722.
3Chislain PD,Roujeau JC.Treatment of severe drug reactions:Stevens-Johnson syndrome,toxic epidermal necrolysis and hypersensitivity syndrome[J].Dermatol Online J,2002,8:5
4Allende Bandres MA,Izuel Rami M,Urbieta Sanz E,et al.Cross-hypersensitivity syndrome between antiepileptic drugs:report of a case[J].Farm Hosp,2004,28(1):56 ～ 58
5Tas S,Simonart T.Management of drug rash with eosinophilia and systemic symptons (DRESS symptons):an update[J].Dermatology,2003,206(4):353 ～ 356
7Neff P,MeuLi-si mmen C,Kempf W,et al.Lyell syndrome revisited:analysis of 18 cases of severe bullous skin disease in a burns unit[J].Br J Plast Surg,2005,58(1):73 ～ 80
9Bachot N,Revuz J,Roujeau JC.Intravenous immunoglobulin treatment for stevens-Johnson syndrome and toxic epidermal necrolysis:a prospective noncomparative study showing no benefit on mortality or progression[J].Arch Dermatol,2003,139(1):33 ～ 36
2Flach AJ, Smith RE, Fraunfelder FT. Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese- American women[ J ]. Ophthalmology, 1995, 102( 11 ): 1677-1680.
3Shirato S, Kagaya F, Suzuki Y, et al. Stevens-Johnson syndrome induced by methazolamide treatment [J]. Arch Ophthalmol, 1997, 115 (4):550-553.
5Kim SH, Kim M, Lee KW, et al. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis [ J ]. Pharmacogenomics, 2010, 11 (6): 879-884.
7Brackett CC, Singh H, Block JH. Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group [ J ]. Pharmaco-therapy, 2004, 24(7 ): 856-870.
